Elektrofi
Formulating the Future of Biologics™
Founded 2016
Boston, United States
93 employees
Series B
Total: $41.86M
Biotechnology
Boston, United States
93 employees
Series B
Total: $41.86M
Biotechnology
General Information
Get notified when Elektrofi moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Elektrofi
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Elektrofi
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 4 |
|
13 Jun 2022 |
| Grant | •••••• | 1 |
|
05 Sep 2018 |
| Grant | •••••• | 1 |
|
29 Jun 2017 |
Elektrofi Alternatives & Competitors
Elektrofi vs
Rani Therapeutics
United States
Making Oral Biologics a Reality.
Post Ipo Equity
96 employees
Biotechnology, Health and Wellness
Elektrofi vs
Elektrofi vs
Coya Therapeutics, Inc.
United States
Unleashing the power of Tregs to tackle neurodegenerative and autoimmune diseases.
Unknown
17 employees
Biopharma, Biotechnology
FAQ About Elektrofi
Formulating the Future of Biologics™
Elektrofi was founded in 2016.
Elektrofi is headquartered in Boston, United States.
Elektrofi operates in the following industries: Biotechnology.
Elektrofi has approximately 93 employees.
Elektrofi has completed 3 funding rounds, raising a total of $41.86M. The latest funding stage is Series B.
Top alternatives and competitors to Elektrofi include Rani Therapeutics, AcousticaBio, Coya Therapeutics, Inc., Clarametyx Biosciences, Alteogen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elektrofi and Rani Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Elektrofi and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
